While STING is identified as a therapeutic target for I/RI, the temporal dynamics of when STING becomes activated and how this timing influences brain injury severity remains unclear. This knowledge gap is critical for determining optimal therapeutic windows for STING-targeted interventions in stroke. Gap type: open_question Source paper: Stimulator of interferon genes (STING): Key therapeutic targets in ischemia/reperfusion injury. (None, None, PMID:37699319)
Landscape Summary: How does the timing of STING activation during ischemia versus reperfusion phases affect neurological outcomes? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does the timing of STING activation during ischemia versus reperfusion phases affect neurological outcomes? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: